BCBA/ABTD (BCBA/ABTD)

Buenos Aires Stock Exchange: BCBA/ABTD · USD

$27.8

-0.17 (-0.6%)· Recorded snapshot

Market cap	274.9T
Revenue (ttm)	73.5T
Net income (ttm)	7.1T
EPS (ttm)	$1,037
P/E (trailing)	41.3x
P/E (forward)	17.6x
Dividend	$675 (1.58%)
Volume	53

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 73.5T
Net income (ttm): 7.1T
EPS (ttm): $1,037
P/E (trailing): 41.3x
P/E (forward): 17.6x
Market cap: 274.9T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E17.6

P25 n/aP50 n/aP75 n/a

Trailing P/E41.3

P25 n/aP50 n/aP75 n/a

ROE10.6

P25 n/aP50 n/aP75 n/a

ROIC7.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All BCBA/ABTD indicators

Market & fundamental data

Available fields

224

Groups with data

Currency

USD

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-10-21
Employees	122,000
Employees change	7,000
Employees growth	6.09%
Enterprise value	$317.7T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-07-18
Fiscal year end	December
Founded	1888
Industry	Medical Devices
Is primary listing	No
ISIN number	ARDEUT110608
Last earnings date	2026-10-21
Last refreshed	2026-10-28
Market cap	$274.9T
Price	$27.75
Price currency	USD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-27
Symbol	bcba/ABTD
Website	https://www.abbott.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	50.21x
Average P/E ratio (3Y)	27.41x
Average P/E ratio (5Y)	28.1x
Earnings yield	2.42%
EV/Earnings	44.47x
EV/EBIT	25.83x
EV/EBITDA	16.7x
EV/FCF	26.3x
EV/Sales	4.27x
FCF / EV yield	3.8%
FCF yield	4.39%
Forward P/E	17.56x
Graham number	11.38075
Graham upside	-58.99%
Lynch fair value	$3.61
Lynch upside	-87.01%
P/(FCF - SBC) ratio	25.06x
P/(OCF - SBC) ratio	19.38x
P/B ratio	3.48x
P/E ratio	41.25x
P/FCF ratio	22.76x
P/OCF ratio	17.98x
P/S ratio	3.73x
Price/EBITDA ratio	15.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	16.55%
EBITDA margin	24.79%
Effective tax rate	28.36%
FCF margin	16.8%
Gross margin	57.08%
Operating margin	16.55%
Pretax margin	13.61%
Profit margin	9.75%
Profit per employee	$62M
Profitable quarters	34
Profitable years	35
Revenue per employee	$639.5M
ROA	5.33%
ROA (5Y)	6.84%
ROCE	9.01%
ROE	10.58%
ROE (5Y)	19.7%
ROIC	7.25%
ROIC (5Y)	14.92%
SBC / revenue	1.54%
Tax / revenue	3.86%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-66.24%
EPS growth (Q)	-43.69%
EPS growth (QoQ)	-0.12%
EPS growth 10Y	11.38%
EPS growth 3Y	-2.87%
EPS growth 5Y	-7.76%
EPS growth years	0
FCF growth	15.48%
FCF growth 3Y	12.55%
FCF growth 5Y	-1.97%
Gross profit growth	12.07%
Gross profit growth (Q)	17.95%
Gross profit growth 3Y	7.75%
Gross profit growth 5Y	2.62%
Net income growth	-66.37%
Net income growth (Q)	-44.04%
Net income growth (QoQ)	-0.86%
Net income growth 3Y	-3.11%
Net income growth 5Y	-8.3%
Net income growth years	0
OCF growth	9.61%
OCF growth 10Y	13.31%
OCF growth 3Y	9.95%
OCF growth 5Y	-1.4%
Operating income growth	-5.19%
Operating income growth (Q)	-33.06%
Operating income growth 3Y	5.37%
Operating income growth 5Y	-2.23%
Revenue growth	10%
Revenue growth (Q)	14.46%
Revenue growth (QoQ)	3.34%
Revenue growth 10Y	8.82%
Revenue growth 3Y	6.47%
Revenue growth 5Y	2.65%
Revenue growth quarters	11
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-3.2T
Depreciation and amortization	$6.1T
EBIT	$12.2T
EBITDA	$18.2T
EPS	$1,036.67
Financing cash flow	$16.4T
Free cash flow	$12.1T
Free cash flow minus SBC	$11T
Gross profit	$42T
Income taxes	$2.8T
Investing cash flow	$-34.5T
Net borrowing	$25.5T
Net cash flow	$-2.8T
Net income	$7.1T
Operating cash flow minus SBC	$14.2T
Operating income	$12.2T
Revenue	$73.5T
Stock-based compensation	$1.1T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$45,040.68
Debt / EBITDA	2.65
Debt / equity	0.63
Debt / FCF	4.14
Interest coverage	7.87
Net cash (debt)	$-41.4T
Net cash / market cap	-15.07%
Net debt / EBITDA	2.27
Net debt / equity	0.52
Net debt / FCF	3.43
Piotroski F-Score	5
Shareholders' equity	$78.9T
Tangible book value	$-2.1T
Tangible book value per share	$-1,185.28
Total cash	$8.5T
Total debt	$49.9T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.48
Current ratio	1.38
Inventory turnover	2.82
Quick ratio	0.8
Working capital	$10.3T

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.25%
Dividend growth	22.66%
Dividend growth (3Y)	7.4%
Dividend growth years	1
Dividend payment date	2026-11-16
Dividend payment years	6
Dividend payout frequency	Quarterly
Dividend per share	$674.67
Dividend yield	1.58%
Ex-dividend date	2026-10-15
Last dividend	$0.16
Payout ratio	65.1%
Shareholder yield	1.83%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$25.74
1D price change	-0.61%
1M price change	4.44%
1M total return	5.05%
1W price change	1.5%
1W total return	1.5%
1Y price change	-14.48%
1Y return CAGR	-13.01%
1Y total return	-13%
20-day SMA	$26.68
200-day SMA	$26.74
3M price change	4.13%
3M total return	4.74%
3Y price change	5.92%
3Y return CAGR	3.5%
3Y total return	10.87%
50-day SMA	$27.48
50-day SMA vs 200-day SMA	50over200
52-week high	$33.71
52-week high date	2025-12-05
52-week low	$21.31
52-week low date	2026-05-14
5Y price change	-14.62%
5Y return CAGR	-1.86%
5Y total return	-8.97%
6M price change	16.21%
6M total return	17.4%
All-time high	$35.85
All-time high date	2021-12-23
All-time low	$21.31
All-time low date	2026-05-11
Average true range (ATR)	$0.65
Average volume	181.8
Change from 52-week high	-17.68%
Change from 52-week low	30.22%
Change from all-time high	-22.59%
Change from all-time low	30.22%
Change from open	0.73%
Day's gap	-1.33%
Dollar volume	$1,471
High price	$27.75
Low price	$27.41
Monthly RSI	47.76
Open price	$27.55
Position in 52-week range	100%
Previous close	$27.92
Price vs 150-day SMA	7.83%
Price vs 20-day SMA	4.03%
Price vs 200-day SMA	3.77%
Price vs 50-day SMA	0.99%
Relative volume	0.29
RSI	57.63
Sharpe ratio	-0.37
Sortino ratio	-0.36
Volume	53
Weekly RSI	53.47
YTD price change	-13.28%
YTD total return	-11.78%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.7B
Shares change (QoQ)	-0.29%
Shares change (YoY)	-0.25%
Shares held by insiders	0.5%
Shares held by institutions	80.99%
Short ratio	1.9 days

Deeper analysis on BCBA/ABTD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this BCBA/ABTD report

Is a complete BCBA/ABTD research report available?

No complete published report is available for bcba/ABTD (BCBA/ABTD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

274.9T

Revenue (ttm)

73.5T

Net income (ttm)

7.1T

EPS (ttm)

$1,037

P/E (trailing)

41.3x

P/E (forward)

17.6x

Dividend

$675 (1.58%)

Volume

Metric

Value

Amount currency

ARS

Country

United States

Country code

Earnings date

2026-10-21

Employees

122,000

Employees change

7,000

Employees growth

6.09%

Enterprise value

$317.7T

Exchange

Buenos Aires Stock Exchange

Financial currency

USD

Financial report date

2026-09-30

First seen

2026-07-18

Fiscal year end

December

Founded

1888

Industry

Medical Devices

Is primary listing

ISIN number

ARDEUT110608

Last earnings date

2026-10-21

Last refreshed

2026-10-28

Market cap

$274.9T

Price

$27.75

Price currency

USD

Sector

Healthcare

SIC code

3845

Stock price date

2026-10-27

Symbol

bcba/ABTD

Website

https://www.abbott.com

Metric

Value

Average P/E ratio (10Y)

50.21x

Average P/E ratio (3Y)

27.41x

Average P/E ratio (5Y)

28.1x

Earnings yield

2.42%

EV/Earnings

44.47x

EV/EBIT

25.83x

EV/EBITDA

16.7x

EV/FCF

26.3x

EV/Sales

4.27x

FCF / EV yield

3.8%

FCF yield

4.39%

Forward P/E

17.56x

Graham number

11.38075

Graham upside

-58.99%

Lynch fair value

$3.61

Lynch upside

-87.01%

P/(FCF - SBC) ratio

25.06x

P/(OCF - SBC) ratio

19.38x

P/B ratio

3.48x

P/E ratio

41.25x

P/FCF ratio

22.76x

P/OCF ratio

17.98x

P/S ratio

3.73x

Price/EBITDA ratio

15.05x

Metric

Value

EBIT margin

16.55%

EBITDA margin

24.79%

Effective tax rate

28.36%

FCF margin

16.8%

Gross margin

57.08%

Operating margin

16.55%

Pretax margin

13.61%

Profit margin

9.75%

Profit per employee

$62M

Profitable quarters

Profitable years

Revenue per employee

$639.5M

ROA

5.33%

ROA (5Y)

6.84%

ROCE

9.01%

ROE

10.58%

ROE (5Y)

19.7%

ROIC

7.25%

ROIC (5Y)

14.92%

SBC / revenue

1.54%

Tax / revenue

3.86%

Metric

Value

EPS growth

-66.24%

EPS growth (Q)

-43.69%

EPS growth (QoQ)

-0.12%

EPS growth 10Y

11.38%

EPS growth 3Y

-2.87%

EPS growth 5Y

-7.76%

EPS growth years

FCF growth

15.48%

FCF growth 3Y

12.55%

FCF growth 5Y

-1.97%

Gross profit growth

12.07%

Gross profit growth (Q)

17.95%

Gross profit growth 3Y

7.75%

Gross profit growth 5Y

2.62%

Net income growth

-66.37%

Net income growth (Q)

-44.04%

Net income growth (QoQ)

-0.86%

Net income growth 3Y

-3.11%

Net income growth 5Y

-8.3%

Net income growth years

OCF growth

9.61%

OCF growth 10Y

13.31%

OCF growth 3Y

9.95%

OCF growth 5Y

-1.4%

Operating income growth

-5.19%

Operating income growth (Q)

-33.06%

Operating income growth 3Y

5.37%

Operating income growth 5Y

-2.23%

Revenue growth

10%

Revenue growth (Q)

14.46%

Revenue growth (QoQ)

3.34%

Revenue growth 10Y

8.82%

Revenue growth 3Y

6.47%

Revenue growth 5Y

2.65%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

$-3.2T

Depreciation and amortization

$6.1T

EBIT

$12.2T

EBITDA

$18.2T

EPS

$1,036.67

Financing cash flow

$16.4T

Free cash flow

$12.1T

Free cash flow minus SBC

$11T

Gross profit

$42T

Income taxes

$2.8T

Investing cash flow

$-34.5T

Net borrowing

$25.5T

Net cash flow

$-2.8T

Net income

$7.1T

Operating cash flow minus SBC

$14.2T

Operating income

$12.2T

Revenue

$73.5T

Stock-based compensation

$1.1T

Metric

Value

Book value per share

$45,040.68

Debt / EBITDA

2.65

Debt / equity

0.63

Debt / FCF

4.14

Interest coverage

7.87

Net cash (debt)

$-41.4T

Net cash / market cap

-15.07%

Net debt / EBITDA

2.27

Net debt / equity

0.52

Net debt / FCF

3.43

Piotroski F-Score

Shareholders' equity

$78.9T

Tangible book value

$-2.1T

Tangible book value per share

$-1,185.28

Total cash

$8.5T

Total debt

$49.9T

Metric

Value

Asset turnover

0.48

Current ratio

1.38

Inventory turnover

2.82

Quick ratio

0.8

Working capital

$10.3T

Metric

Value

Buyback yield / dilution

0.25%

Dividend growth

22.66%

Dividend growth (3Y)

7.4%

Dividend growth years

Dividend payment date

2026-11-16

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

$674.67

Dividend yield

1.58%

Ex-dividend date

2026-10-15

Last dividend

$0.16

Payout ratio

65.1%

Shareholder yield

1.83%

Metric

Value

150-day SMA

$25.74

1D price change

-0.61%

1M price change

4.44%

1M total return

5.05%

1W price change

1.5%

1W total return

1.5%

1Y price change

-14.48%

1Y return CAGR

-13.01%

1Y total return

-13%

20-day SMA

$26.68

200-day SMA

$26.74

3M price change

4.13%

3M total return

4.74%

3Y price change

5.92%

3Y return CAGR

3.5%

3Y total return

10.87%

50-day SMA

$27.48

50-day SMA vs 200-day SMA

50over200

52-week high

$33.71

52-week high date

2025-12-05

52-week low

$21.31

52-week low date

2026-05-14

5Y price change

-14.62%

5Y return CAGR

-1.86%

5Y total return

-8.97%

6M price change

16.21%

6M total return

17.4%

All-time high

$35.85

All-time high date

2021-12-23

All-time low

$21.31

All-time low date

2026-05-11

Average true range (ATR)

$0.65

Average volume

181.8

Change from 52-week high

-17.68%

Change from 52-week low

30.22%

Change from all-time high

-22.59%

Change from all-time low

30.22%

Change from open

0.73%

Day's gap

-1.33%

Dollar volume

$1,471

High price

$27.75

Low price

$27.41

Monthly RSI

47.76

Open price

$27.55

Position in 52-week range

100%

Previous close

$27.92

Price vs 150-day SMA

7.83%

Price vs 20-day SMA

4.03%

Price vs 200-day SMA

3.77%

Price vs 50-day SMA

0.99%

Relative volume

0.29

RSI

57.63

Sharpe ratio

-0.37

Sortino ratio

-0.36

Volume

Weekly RSI

53.47

YTD price change

-13.28%

YTD total return

-11.78%

Metric

Value

Float

1.7B

Shares change (QoQ)

-0.29%

Shares change (YoY)

-0.25%

Shares held by insiders

0.5%

Shares held by institutions

80.99%

Short ratio

1.9 days

BCBA/ABTD (BCBA/ABTD)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/ABTD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/ABTD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/ABTD

Frequently asked questions

BCBA/ABTD (BCBA/ABTD)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/ABTD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/ABTD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/ABTD

Frequently asked questions